

* Thales shares drop after Q1 sales miss analyst forecasts


FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany risks missing out on new drugs that the Anglo-Swe...


(Alliance News) - AstraZeneca PLC on Tuesday reported positive findings from trial results studying its kidney disease treatment, Ultomiris.


(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that high‑level results from an interim analysis of its Phase III I CAN trial showed Ul...


April 20 (Reuters) - The UK's main stock indexes dipped on Monday in broad-based losses as fears that the U.S.-Iran ceasefire could collapse weighe...


(Alliance News) - AstraZeneca PLC on Monday reported positive phase three results for its monoclonal antibody, Tozorakimab, meeting its primary endpoi...


April 16 (Reuters) - UK's main stock indexes edged higher on Thursday, supported by strength in materials and financials, as hopes grew for a reso...


* Stegra secures funding to complete hydrogen-based steel plant